The promise of glucagon-like peptide 1 receptor agonists (GLP-1RA) for the treatment of obesity: a look at phase 2 and 3 pipelines

Año publicación: 2025

Subir documento: https://www.tandfonline.com/doi/full/10.1080/13543784.2025.2472408

Nombre investigadores: Sten Madsbad, Jens J Holst